Drug Shortage Report for PANTOPRAZOLE SODIUM FOR INJECTION

Last updated on 2022-12-28 History
Report ID 172178
Drug Identification Number 02306727
Brand name PANTOPRAZOLE SODIUM FOR INJECTION
Common or Proper name PANTOPRAZOLE SODIUM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10LYVI
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-10-19
Estimated end date 2022-12-21
Actual end date 2022-12-23
Shortage status Resolved
Updated date 2022-12-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2022-12-28 French Compare
v7 2022-12-28 English Compare
v6 2022-12-28 French Compare
v5 2022-12-28 English Compare
v4 2022-10-20 English Compare
v3 2022-10-19 French Compare
v2 2022-10-19 English Compare
v1 2022-10-19 English Compare

Showing 1 to 8 of 8